Related Experiment Video
Updated: Nov 14, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Relationship Between Systemic Immune-Inflammation Index (SII) and the Severity of Stable Coronary Artery Disease
Mustafa Candemir1, Emrullah Kiziltunç1, Serdar Nurkoç2
1Department of Cardiology, 64001Faculty of Medicine, Gazi University, Ankara, Turkey.
Insights
The systemic immune-inflammation index (SII) is a novel marker that predicts coronary artery disease (CAD) severity. Higher SII levels correlate with more severe coronary atherosclerosis, aiding in risk assessment.
Area of Science:
- Cardiology
- Immunology
- Biochemistry
Background:
- Coronary artery disease (CAD) poses significant health risks.
- Predictive markers for CAD severity are crucial for patient management.
- The systemic immune-inflammation index (SII) is a novel marker derived from routine blood counts.
Purpose of the Study:
- To investigate the association between the systemic immune-inflammation index (SII) and the severity of coronary artery disease (CAD).
- To evaluate if SII provides more valuable information on CAD severity compared to other white blood cell-derived ratios.
- To assess the predictive performance of SII for severe coronary lesions.
Main Methods:
- Retrospective analysis of 669 patients undergoing coronary angiography.
- Calculation of the Systemic Immune-Inflammation Index (SII) using platelet count and neutrophil-to-lymphocyte ratio.
- Determination of coronary atherosclerosis severity using the SYNTAX score (SxS).
- Multivariate logistic regression and correlation analyses were performed.
Main Results:
- The SII was identified as an independent predictor of a high SYNTAX score (SxS) in patients with CAD (OR: 1.004, P = .015).
- A significant positive correlation was observed between SII and SxS (Rho: 0.630, P ≤ .001).
- Receiver-operating characteristic analysis indicated that an SII cutoff of 750 × 10³ predicted severe coronary lesions with 86.2% sensitivity and 87.3% specificity.
Conclusions:
- The Systemic Immune-Inflammation Index (SII) is significantly associated with the severity of coronary artery disease (CAD) and high SYNTAX scores (SxS).
- SII is a valuable, inexpensive, and easily measurable laboratory marker for assessing CAD severity in patients with stable angina.
- SII may offer additional prognostic information beyond traditional risk factors in CAD assessment.
Abstract:
Systemic immune-inflammation index (SII; platelet count × neutrophil-to-lymphocyte ratio), a novel marker, predicts adverse clinical outcomes in coronary artery diseases (CAD). We hypothesized that SII could provide more valuable information in assessing the severity of CAD than ratios obtained from other white blood cell subtypes. Patients (n = 669) who underwent coronary angiography were analyzed in this retrospective study. We analyzed the relation between the SII and the angiographic severity of CAD. The severity of coronary atherosclerosis was determined by the SYNTAX score (SxS). Patients with CAD were divided into 3 groups according to the SxS. Multivariate logistic analysis was used to assess risk factors of CAD. In multivariate logistic regression analysis, the SII (odds ratio: 1.004; 95% CI: 1.001-1.007; P = .015) was an independent predictor of high SxS. Additionally, there was a positive correlation between SII and SxS (Rho: 0.630, P ≤ .001). In the receiver-operating characteristic curve analysis, SII with an optimal cutoff value of 750 × 103 predicted the severe coronary lesion with a sensitivity of 86.2% and specificity of 87.3%. The SII, an inexpensive and easily measurable laboratory variable, was significantly associated with the severity of CAD and high SxS in patients with stable angina pectoris.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Coronary Artery Disease I: Introduction
Myocarditis I: Introduction
Coronary Artery Disease II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies